基本信息 产品详情 公司简介 推荐产品
网站主页 化合物 RESOMELAGON 化合物 Resomelagon
  • 化合物 Resomelagon|T60655|TargetMol

化合物 Resomelagon|T60655|TargetMol

Resomelagon
1809420-71-0
1270 2mg 起订
2350 5mg 起订
8160 25mg 起订
上海 更新日期:2025-11-17

TargetMol中国(陶术生物)

VIP2年
联系人:邵小姐
手机:15002134094 拨打
邮箱:marketing@targetmol.cn

产品详情:

中文名称:
化合物 Resomelagon
英文名称:
Resomelagon
CAS号:
1809420-71-0
品牌:
TargetMol
产地:
美国
保存条件:
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
产品类别:
抑制剂
货号:
T60655

Product Introduction

Bioactivity

名称Resomelagon
描述Resomelagon (AP1189) is a potent, orally active agonist of melanocortin receptor (MR) that induces Ca2+ mobilization and ERK1/2 phosphorylation. Resomelagon shows anti-inflammatory activity that can be used in obesity and chronic inflammation research [1] [2].
体外活性Resomelagon (AP1189) (0-1000 μM; 8 min; HEK293A cells) promotes melanocortin signal transduction through ERK1/2 phosphorylation and Ca 2+ mobilization [1]. Resomelagon (AP1189) (1 nM; 30 min; peritoneal macrophages) has anti-inflammatory activity and inhibits TNF-α release and efferocytosis [1]. Western Blot Analysis [1] Cell Line: HEK293A cells Concentration: 0-1000 μM Incubation Time: 8 minutes Result: Increased the expression of ERK1/2 phosphorylation in a dose-dependent manner.
体内活性Resomelagon (AP1189) (0-10 mg/kg; i.p., i.v. and p.o.; for 24 h; male C57BL/6J wild-type (WT) and BALB/c mice) promotes resolution of acute inflammation in vivo [1]. Resomelagon (AP1189) (25-50 mg/kg; p.o.; daily, for 8 d; male C57BL/6J wild-type (WT) and BALB/c mice) reduces arthritis in mice [1]. Animal Model: Male C57BL/6J wild-type (WT) and BALB/c mice [1] Dosage: 0, 0.1, 1 and 10 mg/kg Administration: Oral administration, intraperitoneal injection and intravenous injection; for 24 hours Result: Inhibited neutrophil and monocyte infiltration in a dose-dependent manner. Animal Model: Male C57BL/6J wild-type (WT) and BALB/c mice [1] Dosage: 25 and 50 mg/kg Administration: Oral administration; daily; for 8 days Result: Reduced all signs of arthritis measured, including clinical score ( 42%), paw swelling ( 87%), proportion of animals with all four paws affected ( 50%), and the severity of the inflammation ( 70%).
存储条件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
相关产品Undecylenoyl phenylalanine | HS 014 acetate(207678-81-7 free base) | α-MSH, amide Acetate | BMS-470539 dihydrochloride | Fenoprofen | HS024 | [D-Trp8]-γ-MSH acetate(321351-81-9 free base) | ACTH (1-17) acetate | Nonapeptide-1 acetate salt (158563-45-2 free base) | α-MSH acetate | (±)-Eriodictyol | MCL0020
Resomelagon|TargetMol

公司简介

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿,致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区,已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库,以及多种类型的生化试剂产品,包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等,此外,我们还建设有CADD(计算机辅助药物设计)研究中心、药理实验室、药化合成平台三大技术中心,全方位满足客户的定制需求。 凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持,我们将有效帮助您缩短研发周期,取得更成功的结果。

成立日期 (13年)
注册资本 589.8595万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,天然产物,生物化工,化学试剂,生物技术服务

化合物 Resomelagon相关厂家报价

内容声明
拨打电话 立即询价